Abstract
Myasthenia gravis (MG) is now well established as an autoimmune disease mediated by antibodies to acetylcholine receptors which initiate structural damage to the motor end plate. Simplification of the normally complex junctional folds of the end plate correlates with defective neuromuscular transmission (Figures 7.1–7.3, Diagrams 7.1 and 7.2). There is a distinctive clinical picture of increased fatiguability and temporary muscle weakness. Initial symptoms are often ptosis, diplopia or blurring of vision, due to involvement of the extra-ocular muscles. In the majority of patients the disease soon becomes generalized, affecting speech and swallowing as well as limb muscles1. Sometimes there is severe bulbar weakness with sparing of limb muscles. The most severe generalized disease involves the respiratory muscles, increasing susceptibility to chest infection. In approximately 20% of patients, clinical manifestations remain limited to the extra-ocular muscles, although EMG investigation will reveal more widespread abnormalities. It is suggested that if the disease has been localized for a year, further progression is unlikely1. In chronic disease temporary muscle weakness may give way to persistent weakness, accompanied by atrophy. In all patients symptoms tend to fluctuate.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Grob, D. (1983). Clinical manifestations of myasthenia gravis. In Albuquerque, E. X. and Eldefrawi, A. T. (eds.) Myasthenia Gravis. (London: Chapman and Hall), pp. 319–45
Engel, A. G. et al (1981). Recently recognised congenital myasthenic syndromes. Ann. NY Acad. Sci., 377, 614–39
Tindall, R.S.A. (1980). Humoral immunity in myasthenia gravis: effect of steroids and thymectomy. Neurology, 30, 554–7
Burres, S.A., Kanter, M.E., Richman, D. P. and Amason, B.G.W. (1981). Studies on the pathophysiology of chronic d-penicillamine-induced myasthenia. Ann. NY Acad. Sci., 377, 640–51
Lennon, V. A. (1978). The immunopathology of myasthenia gravis. Human Pathol., 9, 541–51
Engel, A.G. (1984). Myasthenia gravis and myasthenic syndromes. Ann. Neurol., 16, 51 9–34
Engel, A.G., Sahashi, K. and FumagaHi, G. (1981). The immunopathology of acquired myasthenia gravis. Ann. NY Acad. Sci., 377, 159–74
Biesecker, G. and Koffler, D. (1983). Immunology of myasthenia gravis. Human Pathol., 14, 41 9–23
Fumagalli, G., Engel, A.G. and Lindstrom, J. (1982). Ultrastructural aspects of acetyl choline receptor turnover at the normal end plate and in auto-immune myasthenia gravis. J. Neuropathol. Exp. Neurol., 41, 567–79
Drachman, D. B. et al. (1981). Antibody-mediated mechanisms of ACh receptor loss in myasthenia gravis: clinical relevance. Ann. NY Acad. Sci., 377, 175–88
Wekerle, H. et aL (1981). Thymic myogenesis, T lymphocytes and the pathogenesis of myasthenia gravis. Ann. NY Acad. Sci., 377, 455–76
Desmedt, J. E. (1983). Electrophysiological validation of myasthenia gravis. In Albuquerque, E.X. and Eldefrawi, A. T. (eds.) Myasthenia Gravis. ( London: Chapman & Hall ), pp. 249–74
Sanders, D. B. (1983). Electrodiagnosis of myasthenia gravis: recent techniques. In Albuquerque, E.X. and Eldefrawi, A.T. (eds.) Myasthenia Gravis. ( London: Chapman & Hall ), pp. 275–96
Behan, W. M.H., Behan, P.O. and Doyle, D. (1982). Association of myasthenia gravis and polymyositis with neoplasia, infection and autoimmune disorders. Acta Neuropathol. (Berl.), 57, 221–9
Duchen, L. W. (1975). Pathology of the innervation of skeletal muscle. In Harrison, C.V. and Weinbren, K. (eds.) Recent Advances in Pathology. ( Edinburgh: Churchill Livingstone ), pp. 215–48
Engel, A.G., Tsujihata, M., Lindstrom, J.M. and Lennon, V.A. (1976). The motor end plate in myasthenia gravis and in experi-mental autoimmune myasthenia gravis. A quantitative ultra- structural study. Ann. NY Acad. Sci., 274, 60–79
Nash, J.E. (1983). Ultrastructure of normal and myasthenic end plates. In Albuquerque, E.X. and Eldefrawi, A.T. (eds.) Myasthenia Gravis. (London: Chapman & Hall), pp. 391–-422
Gutmann, L., Crosby, T. W., Takamori, M. and Martin, J. D. (1972). The Eaton-Lambert syndrome and auto-immune dis¬orders. Am. J. Med., 53, 354–6
Molenaar, P. C., Newsom-Davis, J., Polak, R. L. and Vincent, A. (1982). Eaton-Lambert syndrome: acetyl choline and choline acetyl transferase in skeletal muscle. Neurology, 32, 1 061–5
Lang, B., Newsom-Davis, J.M., Wray, D., Vincent, A. and Murray, N. (1981). Auto-immune aetiology for myasthenic (Eaton-Lambert) syndrome. Lancet, 2, 224–6
Vincent, A. (1983). Humoral immunity in myasthenia gravis and the Eaton-Lambert syndrome. In Albuquerque, E.X. and Eldefrawi, A.T. (eds.) Myasthenia Gravis. (London: Chapman & Hall), pp. 311–16
Santa, T., Engel, A. G. and Lambert, E.G. (1972). Histometric study of neuromuscular junction ultrastructure. II: Myasthenic syndrome. Neurology, 22, 370–6
Fukunaga, H., Engel, A.G., Osame, M. and Lambert, E. H. (1982). Deficiency of presynaptic membrane active zones and active zone associated intramembrane particles in the Lambert-Eaton myasthenic syndrome. In Abstracts of the Fifth International Congress on Neuromuscular Diseases, Marseilles, France
Emery, P. W., Edwards, R.H.T., Rennie, M.J. and Halliday, D. (1984). Protein synthesis in muscle measured in vivo in cachetic patients with cancer. Br. Med. J., 289, 584–6
Heffner, R.R. (1971). Myopathy of embolic origin in patients with carcinoma. Neurology, 21, 840–6
Weller, R.O. and Cervos-Navarro, J. (1977). Neuropathy in malignant disease. In Pathology of Peripheral Nerves. ( London: Butterworths ), pp. 135–6
Gritzman, M.C.D., Fritz, V. U., Perkins, S. and Kaplan, C. L. (1983). Motor neuron disease associated with carcinoma. S. African Med. J., 63, 288–91
Mitchell, D. M. and Olczak, S.A. (1979). Remission of a syndrome indistinguishable from motor neurone disease after resection of bronchial carcinoma. Br. Med. J., 2, 176–7
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1985 Janice R. Anderson
About this chapter
Cite this chapter
Anderson, J.R. (1985). Myasthenia. In: Atlas of Skeletal Muscle Pathology. Current Histopathology, vol 9. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-4866-2_7
Download citation
DOI: https://doi.org/10.1007/978-94-009-4866-2_7
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-8653-0
Online ISBN: 978-94-009-4866-2
eBook Packages: Springer Book Archive